6533b835fe1ef96bd129f4d3

RESEARCH PRODUCT

Self-awareness of cognitive functioning in schizophrenia: Patients and their relatives

Sara PolettiRoberta RiccaboniMarta BosiaEnrico SmeraldiRoberto CavallaroSimona AnselmettiMariachiara Buonocore

subject

AdultMalemedicine.medical_specialtymedicine.medical_treatmentNeuropsychological TestsExecutive FunctionmedicineHumansFamilyCognitive skillFirst-degree relativesPsychiatryBiological PsychiatryPsychiatric Status Rating ScalesRehabilitationCognitionAwarenessmedicine.diseaseExecutive functionsPsychiatry and Mental healthCognitive remediation therapySchizophreniaSchizophreniaFemaleSchizophrenic PsychologyPsychologyCognition DisordersDiagnosis of schizophreniaClinical psychology

description

"Cognitive impairment has been recognized since the earliest descriptions of schizophrenia as a core feature of the illness and different programmes have been developed to remediate these deficits. In all likelihood it is important for compliance and adherence to treatment that not only the patients but also their relatives be aware of the patients; cognitive deficits. Sixty-two patients with a diagnosis of schizophrenia and, for each one of them, one family member and an informant from the medical staff, were recruited and administered the Schizophrenia Cognition Rating Scale (SCoRS) ratings. Patients were tested for cognitive deficits with a neuropsychological battery and their performance was compared to the ratings of cognitive functioning provided by the patient himself, his family member and the informant. Results show no significant association between cognitive performance and SCoRS ratings in patients; only for executive functions the patient's performance was found to be predictive of the respective judgment on the SCoRS that was given by the relative. This is the first study to investigate awareness of the patients' cognitive deficits, both in the patients themselves and in their first degree relatives, through a direct comparison between subjective clinical ratings and objective measures of cognitive performances. When both patients and relatives are unaware of the patients' cognitive deficits, this could affect adherence to remediation treatment and need to be specifically addressed in future rehabilitation strategies." Cognitive impairment has been recognized since the earliest descriptions of schizophrenia as a core feature of the illness and different programmes have been developed to remediate these deficits. In all likelihood it is important for compliance and adherence to treatment that not only the patients but also their relatives be aware of the patients cognitive deficits. 62 patients with a diagnosis of schizophrenia and, for each one of them, one family member and an informant from the medical staff, were recruited and administered the Schizophrenia Cognition Rating Scale. Patients were tested for cognitive deficits with a neuropsychological battery and their performance was compared to the ratings of patients cognitive functioning provided by the patient himself, his family member and the informant. Results show no significant association between cognitive performance and SCoRS ratings in patients; only for executive functions the patient's performance was found to be predictive of the respective judgment at SCoRS given by the relative. This is the first study to investigate awareness of the patients cognitive deficits, both in the patients itself and in first degree relatives, through a direct comparison between subjective clinical ratings and objective measures of cognitive performances. Both patients and relatives are unaware of the patients' cognitive deficits, this could affect adherence to remediation treatment and need to be specifically addressed from future rehabilitation strategies.

10.1016/j.psychres.2011.12.040